Stock listing
HN30 Stock Price, News, Filings & Events — Restart Life Sciences Corp.
Selected listing: HN30 · TRADEGATE · EUR · DE
This page tracks Restart Life Sciences Corp.'s HN30:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HN30:TRADEGATE. HN30:TRADEGATE is the stock-level entry point for investors researching Restart Life Sciences Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- HN30:TRADEGATE
- Asset type
- Stock
- Market cap
- $3.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- TRADEGATE
- Currency
- EUR
Restart Life Sciences Corp. HN30:TRADEGATE stock context
This page tracks Restart Life Sciences Corp.'s HN30:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HN30:TRADEGATE. HN30:TRADEGATE is the stock-level entry point for investors researching Restart Life Sciences Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Restart Life Sciences Corp.
Restart Life Sciences Announces Holy Crap's Amazon U.S. Rollout Alongside Next-Generation Protein and Sampling Innovations
September 1, 2026
Restart Life Sciences Announces Production Launch of New Holy Crap Protein Line
August 11, 2026
Restart Life Sciences Announces Strategic Focus on Targeted M&A Expansion in Health and CPG Sectors
July 29, 2026
Restart Life Sciences Details U.S. E-Commerce Launch, AI Platform, and Three-Phase Expansion Strategy for Holy Crap Foods
July 21, 2026
Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks
July 14, 2026
Research Restart Life Sciences Corp.
Restart Life Sciences Corp. investor report
Review AI stock analysis and investor report context for HN30:TRADEGATE.
Restart Life Sciences Corp. company profile
View the public company page for Restart Life Sciences Corp. on 6ix.
Restart Life Sciences Corp. news
Read company news and market updates connected to Restart Life Sciences Corp..
Restart Life Sciences Corp. investor events
Find investor webinars, events, and replay context for Restart Life Sciences Corp..
Alternate listings
HEAL:CSE
CA · CAD
Alternate listing for Restart Life Sciences Corp.; the primary context on this page is HN30:TRADEGATE.
NMLSF:OTC
US · USD
Alternate listing for Restart Life Sciences Corp.; the primary context on this page is HN30:TRADEGATE.
A410C5:LSX
DE · EUR
Alternate listing for Restart Life Sciences Corp.; the primary context on this page is HN30:TRADEGATE.
A410C5:LS
DE · EUR
Alternate listing for Restart Life Sciences Corp.; the primary context on this page is HN30:TRADEGATE.
HEAL:NEO
CA · CAD
Alternate listing for Restart Life Sciences Corp.; the primary context on this page is HN30:TRADEGATE.
HN30:FWB
DE · EUR
Alternate listing for Restart Life Sciences Corp.; the primary context on this page is HN30:TRADEGATE.
HN30:SWB
DE · EUR
Alternate listing for Restart Life Sciences Corp.; the primary context on this page is HN30:TRADEGATE.